This
page
is
part
of
the
Continuous
Integration
Build
of
FHIR
Specification
(v4.0.1:
R4
-
Mixed
Normative
and
STU
)
in
it's
permanent
home
(it
will
always
(will
be
available
incorrect/inconsistent
at
this
URL).
The
current
version
which
supercedes
this
version
is
5.0.0
.
For
a
full
list
of
available
versions,
see
times).
See
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
| Responsible Owner: Pharmacy Work Group | Standards Status : Informative |
Compartments
:
|
This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationAdministration .
Generated
Narrative
with
Details
Narrative:
MedicationAdministration
medadmin0304
contained
status
:
Completed
|
|
|
Medication
alemtuzumab
10
MG/ML
|
subject : Donald Duck
context
encounter
:
encounter
who
leads
to
this
prescription
effective
occurrence
:
15/01/2015
4:30:00
AM
2015-01-15T04:30:00+01:00
-->
15/01/2015
2:30:00
PM
2015-01-15T14:30:00+01:00
performer
PerformersActors
ActorReferencePatrick Pump
|
|
| Condition Malignant neoplastic disease |
request
:
MedicationRequest/medrx0319
MedicationRequest:
identifier
=
http://www.bmc.nl/portal/prescriptions#12345689 (use: official, );
status
=
completed;
intent
=
order;
authoredOn
=
2015-01-15
| Text | Route | Method | Dose |
| Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk |
Intravenous
route
|
Inject
-
dosing
instruction
imperative
(qualifier
value)
|
3
mg
(Details:
UCUM
|
Generated Narrative: Medication #med0303
code : alemtuzumab 10 MG/ML [Lemtrada]
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.